Transgene Biotek board approves unaudited financial results

07 Aug 2025 Evaluate
With reference to a letter dated 30th July 2025, Transgene Biotek has informed that at a meeting of the Board of Directors of the company held on 07th August 2025 the following decisions have been taken: 1) The Board considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025. 2) The Board considered and approved the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025. 3) The Board considered and approved the extension of the date of Annual General Meeting (AGM) of the Company for the financial year 2024-25. 4) The Board considered and approved the appointment of Manisha Dubey & Associates, as Internal Auditors of the Company for the financial year 2025-26. 5) The Board considered and approved the appointment of Geeta Serwani & Associates, Practicing Company Secretaries as Secretarial Auditor of the Company for the term of 5 years effective from 01st April 2025 till 31st March 2030 which is subject to regularization by shareholders at AGM; (Attached as Annexure A). The meeting commenced at 11.00 AM and concluded at 11.45 AM. 

The above information is a part of company’s filings submitted to BSE.



Transgene Biotek Share Price

2.55 -0.22 (-7.94%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7235.90
Max Healthcare Inst 1036.55
Narayana Hrudayalay 1918.80
Aster DM Healthcare 599.60
Global Health 1144.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×